Neogenomics Inc
NASDAQ:NEO

Watchlist Manager
Neogenomics Inc Logo
Neogenomics Inc
NASDAQ:NEO
Watchlist
Price: 15.83 USD 0.06% Market Closed
Market Cap: 2B USD
Have any thoughts about
Neogenomics Inc?
Write Note

Neogenomics Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Neogenomics Inc
Operating Expenses Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Neogenomics Inc
NASDAQ:NEO
Operating Expenses
-$355.9m
CAGR 3-Years
-17%
CAGR 5-Years
-19%
CAGR 10-Years
-27%
Thermo Fisher Scientific Inc
NYSE:TMO
Operating Expenses
-$10B
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
-7%
Danaher Corp
NYSE:DHR
Operating Expenses
-$8.2B
CAGR 3-Years
7%
CAGR 5-Years
-7%
CAGR 10-Years
-3%
Mettler-Toledo International Inc
NYSE:MTD
Operating Expenses
-$1.2B
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
-3%
Agilent Technologies Inc
NYSE:A
Operating Expenses
-$2B
CAGR 3-Years
2%
CAGR 5-Years
-1%
CAGR 10-Years
-11%
IQVIA Holdings Inc
NYSE:IQV
Operating Expenses
-$3.2B
CAGR 3-Years
0%
CAGR 5-Years
-2%
CAGR 10-Years
-14%

See Also

What is Neogenomics Inc's Operating Expenses?
Operating Expenses
-355.9m USD

Based on the financial report for Jun 30, 2024, Neogenomics Inc's Operating Expenses amounts to -355.9m USD.

What is Neogenomics Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-27%

Over the last year, the Operating Expenses growth was -5%. The average annual Operating Expenses growth rates for Neogenomics Inc have been -17% over the past three years , -19% over the past five years , and -27% over the past ten years .

Back to Top